Skip to main content

READYSTATE ASSET MANAGEMENT LP

Position in GILD — Gilead Sciences, Inc.

CIK 1900923 CHICAGO, IL

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
10 quarters on record

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2026
CallValue
$593,798
CallShares
4,700
PutValue
$341,118
PutShares
2,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

READYSTATE ASSET MANAGEMENT LP holds $5,003,267 across 2 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $593,798 4,700
2026-06-30 $341,118 2,700
2026-03-31 $376,299 2,700
2026-03-31 $655,039 4,700
2025-03-31 $649,553 5,797
2025-03-31 $3,731,265 33,300
2025-03-31 $3,014,145 26,900
2024-12-31 $4,055,043 43,900
2024-12-31 $2,050,614 22,200
2024-09-30 $5,566,976 66,400
2024-09-30 $7,092,864 84,600
2024-03-31 $1,582,200 21,600
2024-03-31 $1,508,950 20,600
2024-03-31 $612,370 8,360
2023-12-31 $3,459,127 42,700
2023-12-31 $170,283 2,102
2023-12-31 $3,459,127 42,700
2023-09-30 $224,820 3,000
2023-09-30 $224,820 3,000
2023-06-30 $231,210 3,000
2023-06-30 $231,210 3,000
2023-03-31 $331,880 4,000
2023-03-31 $331,880 4,000